These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 16014408

  • 21. Significantly high level of late-night free cortisol to creatinine ratio in urine specimen in patients with subclinical Cushing's syndrome.
    Shiwa T, Oki K, Yamane K, Yoneda M, Awaya T, Nakanishi S, Kohno N.
    Clin Endocrinol (Oxf); 2013 Nov; 79(5):617-22. PubMed ID: 23480295
    [Abstract] [Full Text] [Related]

  • 22. An accurate, non-invasive approach to diagnose Cushing's syndrome in at-risk populations.
    Cardoso EM, Arregger AL, Monardes G, Contreras LN.
    Steroids; 2013 May; 78(5):476-82. PubMed ID: 23485687
    [Abstract] [Full Text] [Related]

  • 23. Diagnostic characteristics of late-night salivary cortisol using liquid chromatography-tandem mass spectrometry.
    Zerikly RK, Amiri L, Faiman C, Gupta M, Singh RJ, Nutter B, Kennedy L, Hatipoglu B, Weil RJ, Hamrahian AH.
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4555-9. PubMed ID: 20631023
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC, Raff H, Findling JW.
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.
    Deutschbein T, Unger N, Hinrichs J, Walz MK, Mann K, Petersenn S.
    Eur J Endocrinol; 2009 Nov; 161(5):747-53. PubMed ID: 19726566
    [Abstract] [Full Text] [Related]

  • 31. Reproducibility and performance of one or two samples of salivary cortisol in the diagnosis of Cushing's syndrome using an automated immunoassay system.
    Carrasco CA, García M, Goycoolea M, Cerda J, Bertherat J, Padilla O, Meza D, Wohllk N, Quiroga T.
    Endocrine; 2012 Jun; 41(3):487-93. PubMed ID: 22270871
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of the effectiveness of midnight serum cortisol in the diagnostic procedures for Cushing's syndrome.
    Reimondo G, Allasino B, Bovio S, Paccotti P, Angeli A, Terzolo M.
    Eur J Endocrinol; 2005 Dec; 153(6):803-9. PubMed ID: 16322385
    [Abstract] [Full Text] [Related]

  • 33. Novel insights in the diagnosis of Cushing's syndrome.
    Alexandraki KI, Grossman AB.
    Neuroendocrinology; 2010 Dec; 92 Suppl 1():35-43. PubMed ID: 20829616
    [Abstract] [Full Text] [Related]

  • 34. Late-night salivary cortisol as a screening test for the diagnosis of Cushing's syndrome in Japan.
    Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshimoto T, Hirata Y.
    Endocr J; 2008 Mar; 55(1):121-6. PubMed ID: 18202529
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Determination of nighttime salivary cortisol during pregnancy: comparison with values in non-pregnancy and Cushing's disease.
    Lopes LM, Francisco RP, Galletta MA, Bronstein MD.
    Pituitary; 2016 Feb; 19(1):30-8. PubMed ID: 26346684
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.